UPPSALA, Sweden, March 25, 2003 (PRIMEZONE) -- Personal Chemistry, the market leader in microwave synthesis, announces Emrys Optimizer(TM) with dynamic volume capability allowing users to synthesise compounds in reaction volumes between 0.2-20 ml, a dynamic range of 100x.
The system uses an intuitive software menu giving full support for several individual users. Vials can be chosen independently and run in sequence - independent of scale - without any manual changes to the instrument. The increase in throughput is exponential to alternative chemistry approaches.
The system will allow set up of 1 - 60 vials at one time, allowing complete operator flexibility and safety as chemistry can be conveniently scaled from mg - g, without any system change. This capability is available on new instruments or, as a separate field upgrade for older models. A user can have 10g of a compound ready in just 2 hours!
EVP of World Wide sales Scott Carr states, "this advancement in our technology has raised the bar for microwave assisted synthesis platforms and its use will become wide spread. Between our current installed base and anticipated orders we would expect this improved functionality to be used in hundreds of our systems by the end of 2003. In the past months we have experienced sales growth of 65% over previous year. With this new capability and our recently launched knowledge products we expect to continue growing our market share in the Pharma and Biotech sectors."
For the challenging and flexible environment of lead compound development chemists, all Emrys instruments share the batch reaction format, the only platform to support full chemistry diversity, without limits in either scope or scale.
Please visit us at:
ACS National Meeting; New Orleans; March 23 - 27, Booth 1426. DDT 2003, Stuttgart, Germany; March 31 - April 4, Booth 1.11 MCR, Genova, Italy; April 14 - 16
Personal Chemistry, a private Swedish company, is the market leader in instrumentation, knowledge products, reaction kits and accessories for microwave-assisted synthesis. Having manufactured the first purpose-built systems in 2000, Personal Chemistry has installed close to 300 systems, and counts all the top pharmaceutical and biotech companies among its customers. Personal Chemistry develops and markets Coherent Synthesis(TM), a complete solution for faster, higher quality chemistry development, targeting the needs of medicinal chemistry in drug discovery. The growth rate of Coherent Synthesis is high; to date, over 350,000 microwave synthesis reactions have been run, with an estimated growth rate of 10,000 reactions per week, world wide.
The company has its headquarters in Uppsala, Sweden and subsidiaries in Boston (US), Cambridge (UK) and Konstanz (Germany). Personal Chemistry currently employs 100 people of whom more than 30 are chemists. The company was founded in 1998 and the main share holders are Health Cap, Investor Growth Capital, 3i, and SEB Foretagsinvest.
Please visit our website at http://www.personalchemistry.com/
For further information, please contact:
Trisha Hanger, Dowell Stubbs, +46 8 545 68813
Robert England, Personal Chemistry, +46 18 489 9000